Clinical services for AIDS patients at the University of California, San Francisco (UCSF) expanded rapidly from the onset of the epidemic and became particularly focused at the San Francisco General Hospital (SFGH) Campus under the directorship of Paul A. Volberding, M.D. The J. David Gladstone Foundation decided to extend their organization's research activities beyond atherosclerosis to basic AIDS research. Since the Gladstone Foundation Laboratories were already located at SFGH and SFGH was also the site of one of the earliest AIDS medical care facilities, and now an internationally recognized treatment center for HIV-infected persons and AIDS patients, extending the organization to basic science in AIDS was a natural choice. In a joint effort between the Trustees of the Gladstone Foundation, the City and County of San Francisco, and UCSF, resources were combined to complete, furnish and equip a 27,000 square foot facility dedicated to basic research on AIDS. This facility is the Gladstone Institute of Virology and Immunology and is directed by an internationally recognized immunologist and virologist, Warner C. Greene, M.D., Ph.D. The CFAR theme of transnational research will be set by the shared responsibilities of Co-Directors, Drs. Volberding and Greene and by inclusion of the following core facilities: A) Clinical, with Biostatistical, Behavioral and Tissue Bank sub-cores, B) Clinical Virology, C) Flow Cytometry D) Molecular Biology, and E) Immunocytopathology. Usage of these core facilities will be targeted at multidisciplinary collaborations. Developmental activities of the UCSF CFAR will include New Investigator Awards, Pilot Project Grants and short term support for Evolving Research Opportunities. The UCSF CFAR will also continue to support focused scientific workshop which will be designed to bring UCSF investigators together with key outside scientists to facilitate an effective, collaborative approach among UCSF investigators in key areas. The current application continues the involvement of many of the established UCSF investigator from the original CFAR but also serves to build on the new research base within the Gladstone Institute of Virology and Immunology. The proposed CFAR represents an important evolution in the history of the San Francisco CFAR and specifically seeks to bridge the gap between the clinical and basic science disciplines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027763-07
Application #
2064076
Study Section
Special Emphasis Panel (SRC (70))
Project Start
1988-09-30
Project End
1999-02-28
Budget Start
1995-03-01
Budget End
1996-02-29
Support Year
7
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Chammartin, Frédérique; Zürcher, Kathrin; Keiser, Olivia et al. (2018) Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysis. Clin Infect Dis 67:1643-1652
Pulugulla, Sree H; Packard, Thomas A; Galloway, Nicole L K et al. (2018) Distinct mechanisms regulate IL1B gene transcription in lymphoid CD4 T cells and monocytes. Cytokine 111:373-381
Mohamed, Tamer M A; Ang, Yen-Sin; Radzinsky, Ethan et al. (2018) Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration. Cell 173:104-116.e12
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Vardi, Noam; Chaturvedi, Sonali; Weinberger, Leor S (2018) Feedback-mediated signal conversion promotes viral fitness. Proc Natl Acad Sci U S A 115:E8803-E8810
Carrico, Adam W; Flentje, Annesa; Kober, Kord et al. (2018) Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection. Brain Behav Immun 71:108-115
Tymejczyk, Olga; Brazier, Ellen; Yiannoutsos, Constantin et al. (2018) HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries. PLoS Med 15:e1002534
Sauceda, John A; Lisha, Nadra E; Neilands, Torsten B et al. (2018) Cognitive-affective depressive symptoms and substance use among Latino and non-Latino White patients in HIV care: an analysis of the CFAR network of integrated clinical systems cohort. J Behav Med :
Carrico, Adam W; Cherenack, Emily M; Roach, Margaret E et al. (2018) Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection. AIDS 32:767-771
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786

Showing the most recent 10 out of 1541 publications